Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.0K
Overview
51.0K
Preventive Healthcare Services01:30

Preventive Healthcare Services

1.8K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.8K
Development of Immunocompetence01:22

Development of Immunocompetence

726
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
726
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

3.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

1.8K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.8K
Prevalence and Incidence01:08

Prevalence and Incidence

1.4K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note: Surface modification minimizes the toxicity of silver nanoparticles: an in vitro and in vivo study.

Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry·2026
Same author

Vaccine uptake in the context of mandate announcement and removal: Evidence from Europe and North America.

Vaccine·2026
Same author

Mpox disease epidemiology, vaccine uptake and vaccination coverage in Australia 2022-2024: a descriptive study.

EClinicalMedicine·2026
Same author

Annual immunisation coverage report 2024.

Communicable diseases intelligence (2018)·2026
Same author

ATAGI 2024 Annual Statement on Immunisation.

Communicable diseases intelligence (2018)·2026
Same author

ATAGI 2025 Annual Statement on Immunisation.

Communicable diseases intelligence (2018)·2026
Same journal

Measles epidemiology in Australia: 2014 to 2024. Erratum to 10.33321/cdi.2026.50.016.

Communicable diseases intelligence (2018)·2026
Same journal

Presymptomatic transmission, vaccine breakthrough and anonymous contacts: a cluster of mpox in Canberra, Australian Capital Territory, 2024.

Communicable diseases intelligence (2018)·2026
Same journal

The Strategic Plan for Tuberculosis Elimination and Equity in Australia 2026-2030.

Communicable diseases intelligence (2018)·2026
Same journal

An atlas of common Salmonella serotypes from routinely notified human cases in the Northern Territory of Australia, 2005-2024.

Communicable diseases intelligence (2018)·2026
Same journal

Meningococcal Surveillance Australia: Reporting period 1 October to 31 December 2025.

Communicable diseases intelligence (2018)·2026
Same journal

Australian Gonococcal Surveillance Program, 1 October to 31 December 2025.

Communicable diseases intelligence (2018)·2026
See all related articles

Related Experiment Video

Updated: Jan 3, 2026

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.7K

Annual Immunisation Coverage Report 2017.

Brynley Hull1, Alexandra Hendry1, Aditi Dey1

  • 1National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children's Hospital at Westmead and University of Sydney, Locked Bag 4001, Westmead, NSW 2145.

Communicable Diseases Intelligence (2018)
|November 19, 2019
PubMed
Summary
This summary is machine-generated.

In 2017, Australia saw increased childhood immunisation coverage, with record highs for Indigenous children. Human Papillomavirus (HPV) vaccination course completion was also reported for Indigenous adolescents for the first time.

Keywords:
Indigenous immunisation coverageadolescent immunisation coveragehuman papillomavirus vaccine coverageimmunisation coverageimmunisation delayinfluenza vaccination

More Related Videos

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.1K
Author Spotlight: Rabies-Specific Antibody Isotypes Detection in Sera or Cerebral Spinal Fluid Using an IFA Test
07:54

Author Spotlight: Rabies-Specific Antibody Isotypes Detection in Sera or Cerebral Spinal Fluid Using an IFA Test

Published on: January 19, 2024

3.1K

Related Experiment Videos

Last Updated: Jan 3, 2026

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.7K
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.1K
Author Spotlight: Rabies-Specific Antibody Isotypes Detection in Sera or Cerebral Spinal Fluid Using an IFA Test
07:54

Author Spotlight: Rabies-Specific Antibody Isotypes Detection in Sera or Cerebral Spinal Fluid Using an IFA Test

Published on: January 19, 2024

3.1K

Area of Science:

  • Public Health
  • Immunology
  • Vaccinology

Background:

  • The Australian Immunisation Register (AIR) and National Human Papillomavirus (HPV) Vaccination Program Register collect national vaccination data.
  • Annual reports track immunisation coverage trends and program effectiveness.
  • This report is the first to include HPV vaccine course completion data for Aboriginal and Torres Strait Islander (Indigenous) adolescents.

Purpose of the Study:

  • To report national immunisation coverage data for the calendar year 2017.
  • To present the first data on HPV vaccine course completion in Indigenous adolescents.
  • To analyze vaccination coverage trends across different age groups and demographics.

Main Methods:

  • Data extraction from the Australian Immunisation Register (AIR) and the National Human Papillomavirus (HPV) Vaccination Program Register for 2017.
  • Analysis of 'fully immunised' status at 12, 24, and 60 months of age.
  • Calculation of HPV vaccine course completion rates for 15-year-old males and females, including Indigenous and non-Indigenous populations.
  • Comparison of catch-up vaccination rates for measles-mumps-rubella (MMR) containing vaccine in adolescents.

Main Results:

  • 'Fully immunised' coverage reached 93.8% at 12 months and 94.5% at 60 months.
  • Coverage at 24 months slightly decreased to 89.8% due to updated DTPa vaccination schedule.
  • Indigenous children achieved record high 'fully immunised' coverage of 93.2% (12 months) and 96.9% (60 months).
  • HPV vaccine course completion in 15-year-olds was 80.2% for females and 75.9% for males.
  • Indigenous adolescents had lower HPV vaccine course completion rates (79% girls, 77% boys) compared to non-Indigenous (91% girls, 90% boys).
  • Catch-up MMR vaccination was significantly higher in Indigenous adolescents (20.3%) than non-Indigenous (6.4%).

Conclusions:

  • Childhood immunisation coverage in Australia remains high and is increasing at key developmental milestones.
  • Record vaccination coverage achieved in Indigenous children highlights progress in equitable healthcare access.
  • Lower HPV vaccine course completion in Indigenous adolescents warrants further investigation and targeted interventions.
  • The data provides crucial insights into the effectiveness of national vaccination programs and identifies areas for improvement.